Kalmente

Mometasone furoate, the active ingredient in Kalmente, is a corticosteroid (glucocorticoid) presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, in adults and children, and meets EU regulatory standards for safety and efficacy.

GNH USA supplies Kalmente as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable global distribution and supporting quality assurance throughout the supply chain. Our network ensures timely delivery and compliance with local import requirements.

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages.

- Allergic rhinitis: reduces nasal congestion, itching and sneezing. - Seasonal allergic rhinitis: provides symptom relief during pollen exposure periods. - Perennial allergic rhinitis: controls year‑round nasal inflammation and associated symptoms.

Nasal administration of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Unpleasant taste or throat irritation.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes such as blurred vision or cataract formation (rare).

Before using Kalmente, consider the following precautions to ensure safe and effective therapy.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Pediatric use: follow prescriber guidance; safety established for children above the approved age. - Local infection: avoid use if an active nasal or sinus infection is present. - Surgery: discontinue the spray prior to nasal or sinus surgery as advised by the surgeon. - Long‑term use: monitor for signs of adrenal suppression or ocular effects during extended therapy. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase the risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure and heighten adverse effect potential.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., fluconazole): may modestly increase mometasone levels. - Ritonavir or other protease inhibitors: may elevate exposure and require monitoring. - Live nasal vaccines (e.g., live attenuated influenza vaccine): effectiveness may be reduced; consider timing of administration.